Beck Bode LLC’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-32,998
Closed -$10.7M 133
2024
Q1
$10.7M Buy
32,998
+2,576
+8% +$632K 2.19% 18
2023
Q4
$5.8M Buy
+30,422
New +$5.75M 1.3% 26
2023
Q3
Sell
-4,514
Closed -$1.29M 157
2023
Q2
$1.29M Sell
4,514
-199
-4% -$55.3K 0.31% 84
2023
Q1
$1.02M Sell
4,713
-11,983
-72% -$2.33M 0.25% 97
2022
Q4
$3.43M Sell
16,696
-717
-4% -$181K 0.77% 48
2022
Q3
$4.84M Sell
17,413
-135
-0.8% -$34.3K 1.05% 30
2022
Q2
$3.35M Buy
17,548
+10,432
+147% +$1.84M 0.71% 40
2022
Q1
$1.48M Buy
+7,116
New +$1.17M 0.33% 59

Other funds holding SWAV

Beck Bode LLC's SWAV Position: Q2 2024 in Review

Beck Bode LLC sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 32,998 shares — an estimated $10.7M sold.

Beck Bode LLC first reported a position in SWAV in Q1 2022 and held it in 8 quarters. The position peaked at $10.7M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Beck Bode LLC reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Beck Bode LLC sold 32,998 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $10.7M.
  • Beck Bode LLC first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Beck Bode LLC's Shockwave Medical, Inc. Common Stock position peaked at $10.7M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Beck Bode LLC's 13F filing for Q2 2024, filed 12 Aug 2024.